看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。- _1 q+ F a" W* P4 E2 d0 m& h# K
4 X' z0 B! l0 H* j
6 B$ X$ c; ~" e5 k3 [Currently available feasibility data for possible combination strategies.
n$ x- S5 n8 {; G$ j————————————————————————————————1 h* e9 t& ]2 |: h8 e
Combination Feasibility according to preliminary data ) L( H) I0 x, j! n: k6 p( h
——————————————————————————————————
3 v! Q! C- Q) W) LBevacizumab + sorafenib Yes, reduced dose
6 z/ p% |4 |- |5 a! Z/ p# _( GBevacizumab + sunitinib† No 7 s& g+ _% X. w- \9 E) K
Bevacizumab + temsirolimus Yes
2 N) F2 O2 F _; d8 VBevacizumab + everolimus Yes , ?( [6 i2 _ ]
Sorafenib + sunitinib ?
: c. a0 j- @: j N- m/ [" K/ \Sorafenib + temsirolimus Yes, reduced dose
c1 c% b" d6 w& v) k6 u8 fSorafenib + everolimus Yes, reduced dose
. ?0 v. D8 \0 n. {+ e# \Sunitinib + temsirolimus† No # @- d# n$ ]1 ?6 S$ a
Sunitinib + everolimus ?
2 M6 r4 S4 ~) L; M7 xTemsirolimus + everolimus ?
: D6 M. D |2 d) K3 r: d1 J$ r————————————————————7 ? o( U7 @: l3 J+ P
†Led to US FDA warning.0 ^( \' U) l( I& A4 a, z3 H
?: As yet unattempted combination.' @; z5 R, P5 K+ ^6 f( f, H# a$ m2 U) w5 r
|